D. Clapp

  • 6927 Citations
  • 45 h-Index
1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where D. Clapp is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 20 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

NIH Grants

Developmental and HyperActive Ras Tumor SPORE

Clapp, D., Shannon, K. M., Nakamura, J., Skapek, S. & Johnson, G. L.

National Institutes of Health

9/1/158/31/20

Project: Research project

  • Publications

    Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1

    Armstrong, A. E., Rhodes, S. D., Smith, A., Chen, S., Bessler, W., Ferguson, M. J., Jiang, L., Li, X., Yuan, J., Yang, X., Yang, F-C., Robertson, K. A., Ingram, D. A., Blakeley, J. O. & Clapp, D. W., Jan 1 2020, (Accepted/In press) In : Pediatric Blood and Cancer. 67, 8, e28372.

    Research output: Contribution to journalArticle

  • Guanfacine treatment improves ADHD phenotypes of impulsivity and hyperactivity in a neurofibromatosis type 1 mouse model

    Lukkes, J. L., Drozd, H. P., Fitz, S. D., Molosh, A. I., Clapp, D. W. & Shekhar, A., Jan 15 2020, In : Journal of Neurodevelopmental Disorders. 12, 1, 2.

    Research output: Contribution to journalArticle

    Open Access
  • A proteasome-resistant fragment of NIK mediates oncogenic NF-κ B signaling in schwannomas

    Gehlhausen, J. R., Hawley, E., Wahle, B. M., He, Y., Edwards, D., Rhodes, S. D., Lajiness, J. D., Staser, K., Chen, S., Yang, X., Yuan, J., Li, X., Jiang, L., Smith, A., Bessler, W., Sandusky, G., Stemmer-Rachamimov, A., Stuhlmiller, T. J., Angus, S. P., Johnson, G. L. & 4 others, Nalepa, G., Yates, C. W., Wade Clapp, D. & Park, S. J., Jan 1 2019, In : Human molecular genetics. 28, 4, p. 572-583 12 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations

    Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation

    Rhodes, S. D., He, Y., Smith, A., Jiang, L., Lu, Q., Mund, J., Li, X., Bessler, W., Qian, S., Dyer, W., Sandusky, G. E., Horvai, A. E., Armstrong, A. E. & Clapp, D. W., Aug 15 2019, In : Human molecular genetics. 28, 16, p. 2752-2762 11 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations

    Feasibility of using NF1-GRD and AAV for gene replacement therapy in NF1-associated tumors

    Bai, R. Y., Esposito, D., Tam, A. J., McCormick, F., Riggins, G. J., Wade Clapp, D. & Staedtke, V., Jun 1 2019, In : Gene Therapy. 26, 6, p. 277-286 10 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations